nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRB2—Levobunolol—glaucoma	0.0443	0.0557	CbGbCtD
Asenapine—ADRB2—Metipranolol—glaucoma	0.0443	0.0557	CbGbCtD
Asenapine—ADRB1—Levobunolol—glaucoma	0.0437	0.0548	CbGbCtD
Asenapine—ADRB1—Metipranolol—glaucoma	0.0437	0.0548	CbGbCtD
Asenapine—ADRA2C—Apraclonidine—glaucoma	0.0384	0.0482	CbGbCtD
Asenapine—ADRA2C—Brimonidine—glaucoma	0.0384	0.0482	CbGbCtD
Asenapine—ADRB2—Carteolol—glaucoma	0.0377	0.0473	CbGbCtD
Asenapine—ADRB1—Carteolol—glaucoma	0.0371	0.0466	CbGbCtD
Asenapine—ADRA2B—Brimonidine—glaucoma	0.0364	0.0458	CbGbCtD
Asenapine—ADRA2B—Apraclonidine—glaucoma	0.0364	0.0458	CbGbCtD
Asenapine—ADRA2C—Dipivefrin—glaucoma	0.0307	0.0386	CbGbCtD
Asenapine—ADRA2B—Dipivefrin—glaucoma	0.0291	0.0366	CbGbCtD
Asenapine—ADRB2—Dipivefrin—glaucoma	0.0269	0.0337	CbGbCtD
Asenapine—ADRB2—Betaxolol—glaucoma	0.0255	0.032	CbGbCtD
Asenapine—ADRA2A—Brimonidine—glaucoma	0.0253	0.0318	CbGbCtD
Asenapine—ADRA2A—Apraclonidine—glaucoma	0.0253	0.0318	CbGbCtD
Asenapine—ADRB1—Betaxolol—glaucoma	0.0251	0.0315	CbGbCtD
Asenapine—ADRA1A—Apraclonidine—glaucoma	0.0243	0.0305	CbGbCtD
Asenapine—ADRA2A—Dipivefrin—glaucoma	0.0203	0.0254	CbGbCtD
Asenapine—ADRA1A—Dipivefrin—glaucoma	0.0194	0.0244	CbGbCtD
Asenapine—ADRB2—Timolol—glaucoma	0.0164	0.0206	CbGbCtD
Asenapine—ADRB1—Timolol—glaucoma	0.0162	0.0203	CbGbCtD
Asenapine—ADRA2C—Clonidine—glaucoma	0.0159	0.02	CbGbCtD
Asenapine—ADRA2B—Clonidine—glaucoma	0.0151	0.019	CbGbCtD
Asenapine—ADRA2A—Clonidine—glaucoma	0.0105	0.0132	CbGbCtD
Asenapine—ADRA1A—Clonidine—glaucoma	0.0101	0.0127	CbGbCtD
Asenapine—CYP2D6—Carteolol—glaucoma	0.00946	0.0119	CbGbCtD
Asenapine—CYP1A2—Betaxolol—glaucoma	0.00775	0.00973	CbGbCtD
Asenapine—CYP2D6—Betaxolol—glaucoma	0.00639	0.00802	CbGbCtD
Asenapine—CYP2D6—Methazolamide—glaucoma	0.00484	0.00608	CbGbCtD
Asenapine—CYP3A4—Pilocarpine—glaucoma	0.00456	0.00572	CbGbCtD
Asenapine—CYP1A2—Clonidine—glaucoma	0.00425	0.00533	CbGbCtD
Asenapine—CYP2D6—Timolol—glaucoma	0.00412	0.00517	CbGbCtD
Asenapine—CYP3A4—Brinzolamide—glaucoma	0.00358	0.00449	CbGbCtD
Asenapine—CYP2D6—Clonidine—glaucoma	0.0035	0.00439	CbGbCtD
Asenapine—CYP3A4—Dorzolamide—glaucoma	0.00345	0.00434	CbGbCtD
Asenapine—CYP3A4—Methazolamide—glaucoma	0.00308	0.00387	CbGbCtD
Asenapine—CYP3A4—Acetazolamide—glaucoma	0.00246	0.00309	CbGbCtD
Asenapine—CYP3A4—Clonidine—glaucoma	0.00223	0.00279	CbGbCtD
Asenapine—ADRB2—Treprostinil—Latanoprost—glaucoma	0.0017	1	CbGdCrCtD
Asenapine—Leukopenia—Pilocarpine—glaucoma	0.000235	0.00168	CcSEcCtD
Asenapine—Anxiety—Travoprost—glaucoma	0.000235	0.00168	CcSEcCtD
Asenapine—Nausea—Carteolol—glaucoma	0.000235	0.00168	CcSEcCtD
Asenapine—Headache—Levobunolol—glaucoma	0.000234	0.00167	CcSEcCtD
Asenapine—Shock—Brimonidine—glaucoma	0.000234	0.00167	CcSEcCtD
Asenapine—Depression—Betaxolol—glaucoma	0.000233	0.00167	CcSEcCtD
Asenapine—Nervous system disorder—Brimonidine—glaucoma	0.000233	0.00167	CcSEcCtD
Asenapine—Arthralgia—Brinzolamide—glaucoma	0.000233	0.00167	CcSEcCtD
Asenapine—Tachycardia—Brimonidine—glaucoma	0.000232	0.00166	CcSEcCtD
Asenapine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000232	0.00166	CcSEcCtD
Asenapine—Dry mouth—Dorzolamide—glaucoma	0.000231	0.00166	CcSEcCtD
Asenapine—Loss of consciousness—Pilocarpine—glaucoma	0.000231	0.00165	CcSEcCtD
Asenapine—Nausea—Diclofenamide—glaucoma	0.000231	0.00165	CcSEcCtD
Asenapine—Dry mouth—Travoprost—glaucoma	0.00023	0.00165	CcSEcCtD
Asenapine—Dizziness—Latanoprost—glaucoma	0.000229	0.00164	CcSEcCtD
Asenapine—Stomatitis—Betaxolol—glaucoma	0.000228	0.00163	CcSEcCtD
Asenapine—Dry mouth—Brinzolamide—glaucoma	0.000227	0.00163	CcSEcCtD
Asenapine—Vomiting—Methazolamide—glaucoma	0.000227	0.00163	CcSEcCtD
Asenapine—Anaphylactic shock—Dorzolamide—glaucoma	0.000227	0.00162	CcSEcCtD
Asenapine—Hypertension—Pilocarpine—glaucoma	0.000227	0.00162	CcSEcCtD
Asenapine—Rash—Methazolamide—glaucoma	0.000225	0.00161	CcSEcCtD
Asenapine—Dermatitis—Methazolamide—glaucoma	0.000225	0.00161	CcSEcCtD
Asenapine—Eye disorder—Clonidine—glaucoma	0.000225	0.00161	CcSEcCtD
Asenapine—Nausea—Carbachol—glaucoma	0.000225	0.00161	CcSEcCtD
Asenapine—Headache—Methazolamide—glaucoma	0.000224	0.0016	CcSEcCtD
Asenapine—Breast disorder—Timolol—glaucoma	0.000224	0.0016	CcSEcCtD
Asenapine—Cardiac disorder—Clonidine—glaucoma	0.000224	0.0016	CcSEcCtD
Asenapine—Arthralgia—Pilocarpine—glaucoma	0.000224	0.0016	CcSEcCtD
Asenapine—Shock—Dorzolamide—glaucoma	0.000223	0.0016	CcSEcCtD
Asenapine—Anxiety—Pilocarpine—glaucoma	0.000223	0.00159	CcSEcCtD
Asenapine—Hypotension—Brimonidine—glaucoma	0.000222	0.00159	CcSEcCtD
Asenapine—Nausea—Levobunolol—glaucoma	0.000222	0.00159	CcSEcCtD
Asenapine—Nervous system disorder—Travoprost—glaucoma	0.000221	0.00159	CcSEcCtD
Asenapine—Tachycardia—Travoprost—glaucoma	0.00022	0.00158	CcSEcCtD
Asenapine—Somnolence—Acetazolamide—glaucoma	0.00022	0.00157	CcSEcCtD
Asenapine—Nervous system disorder—Brinzolamide—glaucoma	0.000219	0.00157	CcSEcCtD
Asenapine—Angiopathy—Clonidine—glaucoma	0.000219	0.00156	CcSEcCtD
Asenapine—Rash—Latanoprost—glaucoma	0.000218	0.00156	CcSEcCtD
Asenapine—Agranulocytosis—Betaxolol—glaucoma	0.000218	0.00156	CcSEcCtD
Asenapine—Dermatitis—Latanoprost—glaucoma	0.000218	0.00156	CcSEcCtD
Asenapine—Dyspepsia—Acetazolamide—glaucoma	0.000218	0.00156	CcSEcCtD
Asenapine—Tachycardia—Brinzolamide—glaucoma	0.000218	0.00156	CcSEcCtD
Asenapine—Mediastinal disorder—Clonidine—glaucoma	0.000217	0.00155	CcSEcCtD
Asenapine—Headache—Latanoprost—glaucoma	0.000217	0.00155	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000216	0.00155	CcSEcCtD
Asenapine—Insomnia—Brimonidine—glaucoma	0.000215	0.00154	CcSEcCtD
Asenapine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000214	0.00153	CcSEcCtD
Asenapine—Fatigue—Acetazolamide—glaucoma	0.000213	0.00153	CcSEcCtD
Asenapine—Nausea—Methazolamide—glaucoma	0.000212	0.00152	CcSEcCtD
Asenapine—Hypotension—Dorzolamide—glaucoma	0.000212	0.00152	CcSEcCtD
Asenapine—Dyspnoea—Brimonidine—glaucoma	0.000212	0.00152	CcSEcCtD
Asenapine—Somnolence—Brimonidine—glaucoma	0.000211	0.00151	CcSEcCtD
Asenapine—Mental disorder—Clonidine—glaucoma	0.000211	0.00151	CcSEcCtD
Asenapine—Hypotension—Travoprost—glaucoma	0.000211	0.00151	CcSEcCtD
Asenapine—Shock—Pilocarpine—glaucoma	0.000211	0.00151	CcSEcCtD
Asenapine—Thrombocytopenia—Pilocarpine—glaucoma	0.00021	0.0015	CcSEcCtD
Asenapine—Tachycardia—Pilocarpine—glaucoma	0.000209	0.0015	CcSEcCtD
Asenapine—Dyspepsia—Brimonidine—glaucoma	0.000209	0.0015	CcSEcCtD
Asenapine—Hypotension—Brinzolamide—glaucoma	0.000208	0.00149	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000207	0.00148	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000206	0.00147	CcSEcCtD
Asenapine—Insomnia—Dorzolamide—glaucoma	0.000205	0.00147	CcSEcCtD
Asenapine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000205	0.00147	CcSEcCtD
Asenapine—Fatigue—Brimonidine—glaucoma	0.000205	0.00147	CcSEcCtD
Asenapine—Hypersensitivity—Apraclonidine—glaucoma	0.000204	0.00146	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000203	0.00145	CcSEcCtD
Asenapine—Dyspnoea—Dorzolamide—glaucoma	0.000202	0.00145	CcSEcCtD
Asenapine—Insomnia—Brinzolamide—glaucoma	0.000202	0.00144	CcSEcCtD
Asenapine—Somnolence—Dorzolamide—glaucoma	0.000202	0.00144	CcSEcCtD
Asenapine—Muscle spasms—Clonidine—glaucoma	0.000202	0.00144	CcSEcCtD
Asenapine—Dyspnoea—Travoprost—glaucoma	0.000201	0.00144	CcSEcCtD
Asenapine—Hypotension—Pilocarpine—glaucoma	0.0002	0.00143	CcSEcCtD
Asenapine—Dyspepsia—Dorzolamide—glaucoma	0.0002	0.00143	CcSEcCtD
Asenapine—Dyspnoea—Brinzolamide—glaucoma	0.000199	0.00142	CcSEcCtD
Asenapine—Dyspepsia—Travoprost—glaucoma	0.000199	0.00142	CcSEcCtD
Asenapine—Asthenia—Apraclonidine—glaucoma	0.000198	0.00142	CcSEcCtD
Asenapine—Somnolence—Brinzolamide—glaucoma	0.000198	0.00142	CcSEcCtD
Asenapine—Tremor—Clonidine—glaucoma	0.000196	0.00141	CcSEcCtD
Asenapine—Dyspepsia—Brinzolamide—glaucoma	0.000196	0.00141	CcSEcCtD
Asenapine—Eye disorder—Betaxolol—glaucoma	0.000196	0.0014	CcSEcCtD
Asenapine—Fatigue—Dorzolamide—glaucoma	0.000196	0.0014	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000195	0.0014	CcSEcCtD
Asenapine—Gastrointestinal disorder—Travoprost—glaucoma	0.000195	0.0014	CcSEcCtD
Asenapine—Fatigue—Travoprost—glaucoma	0.000195	0.00139	CcSEcCtD
Asenapine—Cardiac disorder—Betaxolol—glaucoma	0.000195	0.00139	CcSEcCtD
Asenapine—Insomnia—Pilocarpine—glaucoma	0.000194	0.00139	CcSEcCtD
Asenapine—Constipation—Travoprost—glaucoma	0.000193	0.00138	CcSEcCtD
Asenapine—Hyperglycaemia—Timolol—glaucoma	0.000193	0.00138	CcSEcCtD
Asenapine—Agitation—Clonidine—glaucoma	0.000193	0.00138	CcSEcCtD
Asenapine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000192	0.00138	CcSEcCtD
Asenapine—Asthenia—Bimatoprost—glaucoma	0.000192	0.00138	CcSEcCtD
Asenapine—Fatigue—Brinzolamide—glaucoma	0.000192	0.00138	CcSEcCtD
Asenapine—Angioedema—Clonidine—glaucoma	0.000192	0.00137	CcSEcCtD
Asenapine—Dyspnoea—Pilocarpine—glaucoma	0.000191	0.00137	CcSEcCtD
Asenapine—Somnolence—Pilocarpine—glaucoma	0.00019	0.00136	CcSEcCtD
Asenapine—Depression—Timolol—glaucoma	0.00019	0.00136	CcSEcCtD
Asenapine—Angiopathy—Betaxolol—glaucoma	0.00019	0.00136	CcSEcCtD
Asenapine—Immune system disorder—Betaxolol—glaucoma	0.000189	0.00136	CcSEcCtD
Asenapine—Malaise—Clonidine—glaucoma	0.000189	0.00135	CcSEcCtD
Asenapine—Mediastinal disorder—Betaxolol—glaucoma	0.000189	0.00135	CcSEcCtD
Asenapine—Dyspepsia—Pilocarpine—glaucoma	0.000189	0.00135	CcSEcCtD
Asenapine—Syncope—Clonidine—glaucoma	0.000188	0.00135	CcSEcCtD
Asenapine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000185	0.00132	CcSEcCtD
Asenapine—Loss of consciousness—Clonidine—glaucoma	0.000184	0.00132	CcSEcCtD
Asenapine—Mental disorder—Betaxolol—glaucoma	0.000184	0.00132	CcSEcCtD
Asenapine—Constipation—Pilocarpine—glaucoma	0.000183	0.00131	CcSEcCtD
Asenapine—Dizziness—Apraclonidine—glaucoma	0.000183	0.00131	CcSEcCtD
Asenapine—Malnutrition—Betaxolol—glaucoma	0.000183	0.00131	CcSEcCtD
Asenapine—Dysgeusia—Betaxolol—glaucoma	0.000179	0.00128	CcSEcCtD
Asenapine—Arthralgia—Clonidine—glaucoma	0.000179	0.00128	CcSEcCtD
Asenapine—Agranulocytosis—Timolol—glaucoma	0.000178	0.00128	CcSEcCtD
Asenapine—Anxiety—Clonidine—glaucoma	0.000178	0.00127	CcSEcCtD
Asenapine—Asthenia—Acetazolamide—glaucoma	0.000178	0.00127	CcSEcCtD
Asenapine—Dizziness—Bimatoprost—glaucoma	0.000177	0.00127	CcSEcCtD
Asenapine—Vomiting—Apraclonidine—glaucoma	0.000176	0.00126	CcSEcCtD
Asenapine—Muscle spasms—Betaxolol—glaucoma	0.000175	0.00126	CcSEcCtD
Asenapine—Hypersensitivity—Brimonidine—glaucoma	0.000175	0.00125	CcSEcCtD
Asenapine—Dry mouth—Clonidine—glaucoma	0.000175	0.00125	CcSEcCtD
Asenapine—Dermatitis—Apraclonidine—glaucoma	0.000174	0.00125	CcSEcCtD
Asenapine—Headache—Apraclonidine—glaucoma	0.000173	0.00124	CcSEcCtD
Asenapine—Tremor—Betaxolol—glaucoma	0.000171	0.00122	CcSEcCtD
Asenapine—Asthenia—Brimonidine—glaucoma	0.00017	0.00122	CcSEcCtD
Asenapine—Rash—Bimatoprost—glaucoma	0.000169	0.00121	CcSEcCtD
Asenapine—Dermatitis—Bimatoprost—glaucoma	0.000169	0.00121	CcSEcCtD
Asenapine—Oedema peripheral—Timolol—glaucoma	0.000169	0.00121	CcSEcCtD
Asenapine—Anaemia—Betaxolol—glaucoma	0.000169	0.00121	CcSEcCtD
Asenapine—Shock—Clonidine—glaucoma	0.000168	0.00121	CcSEcCtD
Asenapine—Connective tissue disorder—Timolol—glaucoma	0.000168	0.00121	CcSEcCtD
Asenapine—Headache—Bimatoprost—glaucoma	0.000168	0.0012	CcSEcCtD
Asenapine—Nervous system disorder—Clonidine—glaucoma	0.000168	0.0012	CcSEcCtD
Asenapine—Thrombocytopenia—Clonidine—glaucoma	0.000168	0.0012	CcSEcCtD
Asenapine—Hypersensitivity—Dorzolamide—glaucoma	0.000167	0.0012	CcSEcCtD
Asenapine—Tachycardia—Clonidine—glaucoma	0.000167	0.0012	CcSEcCtD
Asenapine—Hypersensitivity—Travoprost—glaucoma	0.000166	0.00119	CcSEcCtD
Asenapine—Malaise—Betaxolol—glaucoma	0.000165	0.00118	CcSEcCtD
Asenapine—Nausea—Apraclonidine—glaucoma	0.000164	0.00118	CcSEcCtD
Asenapine—Hypersensitivity—Brinzolamide—glaucoma	0.000164	0.00118	CcSEcCtD
Asenapine—Syncope—Betaxolol—glaucoma	0.000164	0.00117	CcSEcCtD
Asenapine—Dizziness—Acetazolamide—glaucoma	0.000164	0.00117	CcSEcCtD
Asenapine—Asthenia—Dorzolamide—glaucoma	0.000163	0.00116	CcSEcCtD
Asenapine—Asthenia—Travoprost—glaucoma	0.000162	0.00116	CcSEcCtD
Asenapine—Loss of consciousness—Betaxolol—glaucoma	0.00016	0.00115	CcSEcCtD
Asenapine—Eye disorder—Timolol—glaucoma	0.00016	0.00115	CcSEcCtD
Asenapine—Asthenia—Brinzolamide—glaucoma	0.00016	0.00115	CcSEcCtD
Asenapine—Hypotension—Clonidine—glaucoma	0.00016	0.00114	CcSEcCtD
Asenapine—Nausea—Bimatoprost—glaucoma	0.000159	0.00114	CcSEcCtD
Asenapine—Cardiac disorder—Timolol—glaucoma	0.000159	0.00114	CcSEcCtD
Asenapine—Hypersensitivity—Pilocarpine—glaucoma	0.000158	0.00113	CcSEcCtD
Asenapine—Vomiting—Acetazolamide—glaucoma	0.000157	0.00113	CcSEcCtD
Asenapine—Dizziness—Brimonidine—glaucoma	0.000157	0.00112	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000156	0.00112	CcSEcCtD
Asenapine—Angiopathy—Timolol—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Arthralgia—Betaxolol—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Headache—Acetazolamide—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Anxiety—Betaxolol—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Insomnia—Clonidine—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Immune system disorder—Timolol—glaucoma	0.000155	0.00111	CcSEcCtD
Asenapine—Mediastinal disorder—Timolol—glaucoma	0.000154	0.00111	CcSEcCtD
Asenapine—Asthenia—Pilocarpine—glaucoma	0.000154	0.0011	CcSEcCtD
Asenapine—Dyspnoea—Clonidine—glaucoma	0.000153	0.00109	CcSEcCtD
Asenapine—Somnolence—Clonidine—glaucoma	0.000152	0.00109	CcSEcCtD
Asenapine—Dry mouth—Betaxolol—glaucoma	0.000152	0.00109	CcSEcCtD
Asenapine—Mental disorder—Timolol—glaucoma	0.00015	0.00107	CcSEcCtD
Asenapine—Dizziness—Dorzolamide—glaucoma	0.00015	0.00107	CcSEcCtD
Asenapine—Rash—Brimonidine—glaucoma	0.00015	0.00107	CcSEcCtD
Asenapine—Dermatitis—Brimonidine—glaucoma	0.00015	0.00107	CcSEcCtD
Asenapine—Dizziness—Travoprost—glaucoma	0.000149	0.00107	CcSEcCtD
Asenapine—Malnutrition—Timolol—glaucoma	0.000149	0.00107	CcSEcCtD
Asenapine—Headache—Brimonidine—glaucoma	0.000149	0.00107	CcSEcCtD
Asenapine—Gastrointestinal disorder—Clonidine—glaucoma	0.000148	0.00106	CcSEcCtD
Asenapine—Fatigue—Clonidine—glaucoma	0.000148	0.00106	CcSEcCtD
Asenapine—Dizziness—Brinzolamide—glaucoma	0.000147	0.00106	CcSEcCtD
Asenapine—Nausea—Acetazolamide—glaucoma	0.000147	0.00105	CcSEcCtD
Asenapine—Shock—Betaxolol—glaucoma	0.000147	0.00105	CcSEcCtD
Asenapine—Constipation—Clonidine—glaucoma	0.000146	0.00105	CcSEcCtD
Asenapine—Nervous system disorder—Betaxolol—glaucoma	0.000146	0.00105	CcSEcCtD
Asenapine—Dysgeusia—Timolol—glaucoma	0.000146	0.00105	CcSEcCtD
Asenapine—Thrombocytopenia—Betaxolol—glaucoma	0.000146	0.00104	CcSEcCtD
Asenapine—Tachycardia—Betaxolol—glaucoma	0.000145	0.00104	CcSEcCtD
Asenapine—Vomiting—Dorzolamide—glaucoma	0.000144	0.00103	CcSEcCtD
Asenapine—Rash—Dorzolamide—glaucoma	0.000143	0.00102	CcSEcCtD
Asenapine—Dermatitis—Dorzolamide—glaucoma	0.000143	0.00102	CcSEcCtD
Asenapine—Rash—Travoprost—glaucoma	0.000142	0.00102	CcSEcCtD
Asenapine—Dermatitis—Travoprost—glaucoma	0.000142	0.00102	CcSEcCtD
Asenapine—Headache—Dorzolamide—glaucoma	0.000142	0.00102	CcSEcCtD
Asenapine—Vomiting—Brinzolamide—glaucoma	0.000142	0.00101	CcSEcCtD
Asenapine—Dizziness—Pilocarpine—glaucoma	0.000142	0.00101	CcSEcCtD
Asenapine—Headache—Travoprost—glaucoma	0.000141	0.00101	CcSEcCtD
Asenapine—Nausea—Brimonidine—glaucoma	0.000141	0.00101	CcSEcCtD
Asenapine—Rash—Brinzolamide—glaucoma	0.000141	0.00101	CcSEcCtD
Asenapine—Dermatitis—Brinzolamide—glaucoma	0.00014	0.00101	CcSEcCtD
Asenapine—Headache—Brinzolamide—glaucoma	0.00014	0.001	CcSEcCtD
Asenapine—Hypotension—Betaxolol—glaucoma	0.000139	0.000997	CcSEcCtD
Asenapine—Angioedema—Timolol—glaucoma	0.000136	0.000976	CcSEcCtD
Asenapine—Vomiting—Pilocarpine—glaucoma	0.000136	0.000975	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000136	0.000972	CcSEcCtD
Asenapine—Rash—Pilocarpine—glaucoma	0.000135	0.000967	CcSEcCtD
Asenapine—Dermatitis—Pilocarpine—glaucoma	0.000135	0.000966	CcSEcCtD
Asenapine—Insomnia—Betaxolol—glaucoma	0.000135	0.000965	CcSEcCtD
Asenapine—Nausea—Dorzolamide—glaucoma	0.000135	0.000964	CcSEcCtD
Asenapine—Headache—Pilocarpine—glaucoma	0.000134	0.000961	CcSEcCtD
Asenapine—Nausea—Travoprost—glaucoma	0.000134	0.00096	CcSEcCtD
Asenapine—Syncope—Timolol—glaucoma	0.000134	0.000958	CcSEcCtD
Asenapine—Dyspnoea—Betaxolol—glaucoma	0.000133	0.000951	CcSEcCtD
Asenapine—Nausea—Brinzolamide—glaucoma	0.000132	0.000948	CcSEcCtD
Asenapine—Dyspepsia—Betaxolol—glaucoma	0.000131	0.000939	CcSEcCtD
Asenapine—Loss of consciousness—Timolol—glaucoma	0.000131	0.000938	CcSEcCtD
Asenapine—Hypertension—Timolol—glaucoma	0.000129	0.000922	CcSEcCtD
Asenapine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000129	0.000921	CcSEcCtD
Asenapine—Fatigue—Betaxolol—glaucoma	0.000128	0.00092	CcSEcCtD
Asenapine—Constipation—Betaxolol—glaucoma	0.000127	0.000912	CcSEcCtD
Asenapine—Nausea—Pilocarpine—glaucoma	0.000127	0.000911	CcSEcCtD
Asenapine—Arthralgia—Timolol—glaucoma	0.000127	0.000909	CcSEcCtD
Asenapine—Anxiety—Timolol—glaucoma	0.000127	0.000906	CcSEcCtD
Asenapine—Hypersensitivity—Clonidine—glaucoma	0.000126	0.000903	CcSEcCtD
Asenapine—Dry mouth—Timolol—glaucoma	0.000124	0.000889	CcSEcCtD
Asenapine—Asthenia—Clonidine—glaucoma	0.000123	0.000879	CcSEcCtD
Asenapine—Anaphylactic shock—Timolol—glaucoma	0.000122	0.000871	CcSEcCtD
Asenapine—Shock—Timolol—glaucoma	0.00012	0.000857	CcSEcCtD
Asenapine—Nervous system disorder—Timolol—glaucoma	0.000119	0.000855	CcSEcCtD
Asenapine—Hypotension—Timolol—glaucoma	0.000114	0.000814	CcSEcCtD
Asenapine—Dizziness—Clonidine—glaucoma	0.000113	0.00081	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Timolol—glaucoma	0.000111	0.000794	CcSEcCtD
Asenapine—Insomnia—Timolol—glaucoma	0.00011	0.000788	CcSEcCtD
Asenapine—Hypersensitivity—Betaxolol—glaucoma	0.00011	0.000786	CcSEcCtD
Asenapine—Vomiting—Clonidine—glaucoma	0.000109	0.000779	CcSEcCtD
Asenapine—Dyspnoea—Timolol—glaucoma	0.000109	0.000777	CcSEcCtD
Asenapine—Somnolence—Timolol—glaucoma	0.000108	0.000775	CcSEcCtD
Asenapine—Rash—Clonidine—glaucoma	0.000108	0.000773	CcSEcCtD
Asenapine—Dermatitis—Clonidine—glaucoma	0.000108	0.000772	CcSEcCtD
Asenapine—Headache—Clonidine—glaucoma	0.000107	0.000768	CcSEcCtD
Asenapine—Dyspepsia—Timolol—glaucoma	0.000107	0.000767	CcSEcCtD
Asenapine—Asthenia—Betaxolol—glaucoma	0.000107	0.000765	CcSEcCtD
Asenapine—Gastrointestinal disorder—Timolol—glaucoma	0.000105	0.000752	CcSEcCtD
Asenapine—Fatigue—Timolol—glaucoma	0.000105	0.000751	CcSEcCtD
Asenapine—Nausea—Clonidine—glaucoma	0.000102	0.000728	CcSEcCtD
Asenapine—Dizziness—Betaxolol—glaucoma	9.85e-05	0.000705	CcSEcCtD
Asenapine—Vomiting—Betaxolol—glaucoma	9.47e-05	0.000678	CcSEcCtD
Asenapine—Rash—Betaxolol—glaucoma	9.39e-05	0.000673	CcSEcCtD
Asenapine—Dermatitis—Betaxolol—glaucoma	9.38e-05	0.000672	CcSEcCtD
Asenapine—Headache—Betaxolol—glaucoma	9.33e-05	0.000668	CcSEcCtD
Asenapine—Hypersensitivity—Timolol—glaucoma	8.97e-05	0.000642	CcSEcCtD
Asenapine—Nausea—Betaxolol—glaucoma	8.85e-05	0.000634	CcSEcCtD
Asenapine—Asthenia—Timolol—glaucoma	8.73e-05	0.000625	CcSEcCtD
Asenapine—Dizziness—Timolol—glaucoma	8.05e-05	0.000576	CcSEcCtD
Asenapine—Vomiting—Timolol—glaucoma	7.74e-05	0.000554	CcSEcCtD
Asenapine—Rash—Timolol—glaucoma	7.67e-05	0.000549	CcSEcCtD
Asenapine—Dermatitis—Timolol—glaucoma	7.67e-05	0.000549	CcSEcCtD
Asenapine—Headache—Timolol—glaucoma	7.62e-05	0.000546	CcSEcCtD
Asenapine—Nausea—Timolol—glaucoma	7.23e-05	0.000518	CcSEcCtD
Asenapine—ADRA2C—Metabolism—MTHFR—glaucoma	6.84e-06	0.00011	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	6.82e-06	0.00011	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—FN1—glaucoma	6.81e-06	0.000109	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NGFR—glaucoma	6.81e-06	0.000109	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—APOE—glaucoma	6.78e-06	0.000109	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—C3—glaucoma	6.78e-06	0.000109	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EDN1—glaucoma	6.76e-06	0.000109	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—BAD—glaucoma	6.73e-06	0.000108	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EDN1—glaucoma	6.73e-06	0.000108	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CAV1—glaucoma	6.72e-06	0.000108	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NTRK1—glaucoma	6.72e-06	0.000108	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—FN1—glaucoma	6.7e-06	0.000108	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—BAD—glaucoma	6.62e-06	0.000106	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NTRK1—glaucoma	6.61e-06	0.000106	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NTRK1—glaucoma	6.59e-06	0.000106	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EDN1—glaucoma	6.55e-06	0.000105	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—MMP9—glaucoma	6.54e-06	0.000105	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NGF—glaucoma	6.5e-06	0.000104	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	6.47e-06	0.000104	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NGF—glaucoma	6.44e-06	0.000103	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTT1—glaucoma	6.43e-06	0.000103	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.41e-06	0.000103	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—TP53—glaucoma	6.4e-06	0.000103	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—FN1—glaucoma	6.4e-06	0.000103	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—APOE—glaucoma	6.4e-06	0.000103	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—APOE—glaucoma	6.37e-06	0.000102	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NGF—glaucoma	6.36e-06	0.000102	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.35e-06	0.000102	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CAV1—glaucoma	6.34e-06	0.000102	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NGFR—glaucoma	6.33e-06	0.000102	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—BAD—glaucoma	6.32e-06	0.000101	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—APOE—glaucoma	6.31e-06	0.000101	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—CAV1—glaucoma	6.31e-06	0.000101	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—CDKN1B—glaucoma	6.29e-06	0.000101	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GSTM1—glaucoma	6.28e-06	0.000101	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CAV1—glaucoma	6.25e-06	0.0001	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NGF—glaucoma	6.22e-06	9.98e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CDKN2B—glaucoma	6.19e-06	9.94e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NGF—glaucoma	6.18e-06	9.93e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—C3—glaucoma	6.18e-06	9.92e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—C3—glaucoma	6.12e-06	9.83e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	6.09e-06	9.78e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CDKN2B—glaucoma	6.08e-06	9.76e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—C3—glaucoma	6.04e-06	9.7e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—FN1—glaucoma	6.03e-06	9.69e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NGF—glaucoma	6.01e-06	9.66e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	6.01e-06	9.65e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	5.96e-06	9.57e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—BAD—glaucoma	5.96e-06	9.57e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—FN1—glaucoma	5.95e-06	9.56e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EDN1—glaucoma	5.94e-06	9.54e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—C3—glaucoma	5.91e-06	9.49e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—BAD—glaucoma	5.88e-06	9.44e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—C3—glaucoma	5.88e-06	9.44e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—VEGFA—glaucoma	5.87e-06	9.43e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EDN1—glaucoma	5.84e-06	9.38e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EDN1—glaucoma	5.83e-06	9.36e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—MMP9—glaucoma	5.82e-06	9.35e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—APOE—glaucoma	5.75e-06	9.23e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EDN1—glaucoma	5.72e-06	9.19e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—C3—glaucoma	5.72e-06	9.18e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—APOE—glaucoma	5.7e-06	9.15e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CAV1—glaucoma	5.7e-06	9.15e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CAV1—glaucoma	5.65e-06	9.07e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—APOE—glaucoma	5.63e-06	9.03e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CAV1—glaucoma	5.57e-06	8.95e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—NOS3—glaucoma	5.57e-06	8.94e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—NOS3—glaucoma	5.56e-06	8.93e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—MTHFR—glaucoma	5.55e-06	8.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	5.54e-06	8.9e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—NOS3—glaucoma	5.53e-06	8.87e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—APOE—glaucoma	5.5e-06	8.83e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—APOE—glaucoma	5.47e-06	8.79e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NGF—glaucoma	5.46e-06	8.76e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CAV1—glaucoma	5.45e-06	8.75e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTT1—glaucoma	5.45e-06	8.74e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—FN1—glaucoma	5.42e-06	8.71e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CAV1—glaucoma	5.42e-06	8.71e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—TXN—glaucoma	5.42e-06	8.7e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—NOS3—glaucoma	5.41e-06	8.69e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—FN1—glaucoma	5.37e-06	8.63e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NGF—glaucoma	5.37e-06	8.62e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—BAD—glaucoma	5.36e-06	8.6e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NGF—glaucoma	5.36e-06	8.6e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NOS3—glaucoma	5.32e-06	8.55e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—APOE—glaucoma	5.32e-06	8.55e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EDN1—glaucoma	5.32e-06	8.54e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—BAD—glaucoma	5.31e-06	8.53e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—FN1—glaucoma	5.31e-06	8.52e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CAV1—glaucoma	5.27e-06	8.47e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NGF—glaucoma	5.26e-06	8.44e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—BAD—glaucoma	5.24e-06	8.42e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—VEGFA—glaucoma	5.23e-06	8.4e-05	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—TP53—glaucoma	5.2e-06	8.35e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—C3—glaucoma	5.19e-06	8.33e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—FN1—glaucoma	5.19e-06	8.33e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—APOE—glaucoma	5.17e-06	8.3e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—FN1—glaucoma	5.16e-06	8.29e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—BAD—glaucoma	5.13e-06	8.23e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—CAV1—glaucoma	5.12e-06	8.23e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ABCA1—glaucoma	5.12e-06	8.22e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CYP1B1—glaucoma	5.12e-06	8.22e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—C3—glaucoma	5.1e-06	8.2e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—BAD—glaucoma	5.1e-06	8.19e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—C3—glaucoma	5.09e-06	8.18e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NOS3—glaucoma	5.08e-06	8.16e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—FN1—glaucoma	5.02e-06	8.06e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—C3—glaucoma	5e-06	8.03e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—BAD—glaucoma	4.96e-06	7.96e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NGF—glaucoma	4.89e-06	7.84e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—APOE—glaucoma	4.83e-06	7.75e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CDKN1B—glaucoma	4.82e-06	7.74e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CDKN1B—glaucoma	4.82e-06	7.73e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NOS3—glaucoma	4.79e-06	7.69e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CDKN1B—glaucoma	4.79e-06	7.68e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CAV1—glaucoma	4.79e-06	7.68e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—NOS3—glaucoma	4.77e-06	7.66e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—APOE—glaucoma	4.75e-06	7.63e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—APOE—glaucoma	4.74e-06	7.61e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NOS3—glaucoma	4.73e-06	7.59e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CAV1—glaucoma	4.71e-06	7.56e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CAV1—glaucoma	4.7e-06	7.54e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CDKN1B—glaucoma	4.69e-06	7.52e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—APOE—glaucoma	4.65e-06	7.47e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—C3—glaucoma	4.64e-06	7.46e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CDKN1B—glaucoma	4.61e-06	7.4e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CAV1—glaucoma	4.61e-06	7.4e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—FN1—glaucoma	4.55e-06	7.31e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—BAD—glaucoma	4.5e-06	7.23e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—FN1—glaucoma	4.48e-06	7.2e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—FN1—glaucoma	4.47e-06	7.18e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—glaucoma	4.47e-06	7.17e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—glaucoma	4.46e-06	7.16e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—glaucoma	4.44e-06	7.12e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—glaucoma	4.43e-06	7.12e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—BAD—glaucoma	4.43e-06	7.11e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—BAD—glaucoma	4.42e-06	7.1e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CDKN1B—glaucoma	4.4e-06	7.07e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.39e-06	7.05e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—FN1—glaucoma	4.39e-06	7.05e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PTGS2—glaucoma	4.36e-06	7e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—glaucoma	4.34e-06	6.97e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ABCA1—glaucoma	4.34e-06	6.97e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CYP1B1—glaucoma	4.34e-06	6.97e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—BAD—glaucoma	4.34e-06	6.96e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—glaucoma	4.32e-06	6.94e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NOS3—glaucoma	4.31e-06	6.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CAV1—glaucoma	4.28e-06	6.88e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—glaucoma	4.27e-06	6.86e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NOS3—glaucoma	4.27e-06	6.85e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NOS3—glaucoma	4.21e-06	6.77e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTT1—glaucoma	4.2e-06	6.75e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CDKN1B—glaucoma	4.15e-06	6.67e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NOS3—glaucoma	4.12e-06	6.62e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NOS3—glaucoma	4.1e-06	6.58e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CDKN1B—glaucoma	4.1e-06	6.58e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GSTM1—glaucoma	4.1e-06	6.58e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—glaucoma	4.08e-06	6.55e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—FN1—glaucoma	4.08e-06	6.55e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—BAD—glaucoma	4.03e-06	6.47e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—glaucoma	4.01e-06	6.44e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—glaucoma	4.01e-06	6.43e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NOS3—glaucoma	3.99e-06	6.4e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—glaucoma	3.98e-06	6.39e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—glaucoma	3.95e-06	6.34e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—glaucoma	3.9e-06	6.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—NOS3—glaucoma	3.87e-06	6.22e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—glaucoma	3.85e-06	6.17e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—glaucoma	3.84e-06	6.16e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—glaucoma	3.79e-06	6.09e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CDKN1B—glaucoma	3.73e-06	5.99e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	3.7e-06	5.94e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—glaucoma	3.66e-06	5.88e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CDKN1B—glaucoma	3.65e-06	5.86e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MTHFR—glaucoma	3.62e-06	5.81e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—glaucoma	3.62e-06	5.81e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CDKN1B—glaucoma	3.57e-06	5.73e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—glaucoma	3.56e-06	5.72e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—glaucoma	3.55e-06	5.7e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	3.55e-06	5.7e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—glaucoma	3.54e-06	5.69e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—glaucoma	3.49e-06	5.6e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTM1—glaucoma	3.47e-06	5.57e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—glaucoma	3.46e-06	5.55e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	3.45e-06	5.55e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—glaucoma	3.45e-06	5.54e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—glaucoma	3.43e-06	5.5e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—glaucoma	3.41e-06	5.47e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—glaucoma	3.38e-06	5.43e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—glaucoma	3.37e-06	5.41e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP1B1—glaucoma	3.35e-06	5.38e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCA1—glaucoma	3.35e-06	5.38e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAV1—glaucoma	3.34e-06	5.36e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—glaucoma	3.31e-06	5.31e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—glaucoma	3.29e-06	5.28e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—glaucoma	3.24e-06	5.2e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—glaucoma	3.2e-06	5.14e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CDKN1B—glaucoma	3.13e-06	5.03e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—glaucoma	3.1e-06	4.98e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	3.08e-06	4.95e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CDKN1B—glaucoma	3.08e-06	4.94e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	3.08e-06	4.94e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—glaucoma	3.07e-06	4.92e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—glaucoma	3.04e-06	4.88e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—glaucoma	3.03e-06	4.87e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—glaucoma	3.03e-06	4.86e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	3.02e-06	4.85e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—glaucoma	3.01e-06	4.83e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.97e-06	4.77e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—glaucoma	2.95e-06	4.74e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—glaucoma	2.94e-06	4.73e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—glaucoma	2.9e-06	4.66e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—glaucoma	2.9e-06	4.65e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.87e-06	4.61e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—glaucoma	2.86e-06	4.59e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—glaucoma	2.85e-06	4.58e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—glaucoma	2.85e-06	4.58e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAV1—glaucoma	2.83e-06	4.54e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.81e-06	4.51e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.8e-06	4.49e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—glaucoma	2.77e-06	4.44e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTM1—glaucoma	2.68e-06	4.3e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—glaucoma	2.61e-06	4.19e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—glaucoma	2.61e-06	4.19e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.6e-06	4.17e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—glaucoma	2.57e-06	4.13e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.57e-06	4.12e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—glaucoma	2.56e-06	4.11e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—glaucoma	2.52e-06	4.05e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.51e-06	4.03e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—glaucoma	2.37e-06	3.8e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—glaucoma	2.35e-06	3.77e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.33e-06	3.75e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—glaucoma	2.32e-06	3.73e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—glaucoma	2.31e-06	3.71e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—glaucoma	2.29e-06	3.68e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—glaucoma	2.24e-06	3.6e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—glaucoma	2.23e-06	3.58e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—glaucoma	2.2e-06	3.54e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAV1—glaucoma	2.18e-06	3.5e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—glaucoma	2.17e-06	3.49e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—glaucoma	2.14e-06	3.43e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—glaucoma	1.97e-06	3.16e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—glaucoma	1.96e-06	3.14e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—glaucoma	1.94e-06	3.11e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—glaucoma	1.93e-06	3.11e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—glaucoma	1.9e-06	3.05e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—glaucoma	1.76e-06	2.83e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—glaucoma	1.65e-06	2.65e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—glaucoma	1.51e-06	2.42e-05	CbGpPWpGaD
